The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticariaTorsten Zuberbier, Werner Aberer, Riccardo Asero et al.|Allergy|2018Cited by 1.4k
The <scp>EAACI</scp>/<scp>GA</scp><sup>2</sup><scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and updateTorsten Zuberbier, Marcus Maurer, Werner Aberer et al.|Allergy|2014Cited by 1.2k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticariaTorsten Zuberbier, Hector Ratti Sisa, Knut Brockow et al.|Allergy|2021Cited by 1.2k
The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and updateTorsten Zuberbier, Marcus Maurer, Werner Aberer et al.|Dermatology Review|2015Cited by 428
Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skinMartin Metz, Marcus Maurer|Theranostics|2017Cited by 135